Details of the Drug

General Information of Drug (ID: DM4WYGA)

• Drug Name: GSK3359609
• Synonyms: Feladilimab

Indication

Disease Entry	ICD 11	Status	REF
Squamous head and neck cell carcinom	2D60.0	Phase 2/3	[1]
Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]

• Drug Type: Antibody
• Cross-matching ID:
  UNII: OUP4QB2A3R
  DrugBank ID: DB16415
  TTD ID: D0R7BB
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04128696) Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-3). U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)